Publishes on Blood Pressure and Hypertension Studies, Acute Myocardial Infarction Research, Cardiovascular Health and Disease Prevention. 46 papers and 38.7k citations.
The ESH/ESC Guidelines represent the views of the ESH and ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, however, override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient, and where appropriate and necessary the patient's guardian or carer. It is also the health professional's responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, \nwhether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive \ninterventions designed to achieve disease stabilization or regression. \nThe disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event \ncaused by plaque rupture or erosion. However, the disease is \nchronic, most often progressive, and hence serious, even in clinically \napparently silent periods. The dynamic nature of the CAD process \nresults in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic \ncoronary syndromes (CCS). The Guidelines presented here refer to \nthe management of patients with CCS
The 2013 guidelines on hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) follow the guidelines jointly issued by the two societies in 2003 and 2007 [1,2]. Publication of a new document 6 years after the previous one was felt to be timely because, over this period, important studies have been conducted and many new results \nhave been published on both the diagnosis and treatment of individuals with an elevated blood pressure (BP), making refinements, modifications and expansion of the previous recommendations necessary.
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.